Q3 Earnings Alert: These are the most overvalued right nowSee Overvalued Stocks

Needham reiterates Buy on Synopsys, adjusts FY25 forecast with stronger growth expected in second half

EditorAhmed Abdulazez Abdulkadir
Published 10/22/2024, 08:09 AM
SNPS
-

On Tuesday, Needham maintained its Buy rating on Synopsys (NASDAQ:SNPS), with a steady price target of $640.00. Following a virtual fireside chat with Synopsys CEO Sassine Ghazi and CFO Shelagh Glaser, the firm's analysis yielded four key insights. Firstly, Synopsys believes that a long-term compound annual growth rate (CAGR) of 12% in the Electronic Design Automation (EDA) sector is achievable. Secondly, the slowdown in China's market is expected to be a prolonged event spanning multiple years.

The discussion also revealed that Synopsys management anticipates no significant changes in their business dealings with Intel (NASDAQ:INTC). Additionally, the fiscal year 2025 is projected to be more heavily weighted towards the second half due to an anticipated ramp-up in hardware.

Needham has adjusted its fiscal year 2025 estimates for Synopsys to reflect a lower performance in the first half and a stronger second half of the year. Despite these adjustments, the firm's price target remains unchanged at $640, reiterating confidence in the stock's potential. The insights from the chat with Synopsys's leadership have reinforced Needham's positive stance on the company's outlook.

In other recent news, Synopsys has been the subject of several analyst reports. Mizuho initiated coverage with an Outperform rating and a $650 price target, citing the company's potential growth, particularly following its acquisition of Ansys (NASDAQ:ANSS). Berenberg also initiated coverage with a Buy rating and a $660 price target, highlighting Synopsys's differentiated product offerings in high-growth markets. KeyBanc maintained its Overweight rating with a steady price target of $690, expressing confidence in the company's growth opportunities.

Synopsys reported a 13% increase in revenue and a 27% growth in non-GAAP earnings per share in Q3 2024, surpassing its targets. The company's full-year guidance for 2024 anticipates revenue between $6.105 billion and $6.135 billion, and non-GAAP EPS ranging from $13.07 to $13.12.

In other developments, Synopsys finalized the sale of its Software Integrity business to entities controlled by investment groups Clearlake Capital Group and Francisco Partners.

The company also announced a collaboration with Taiwan Semiconductor Manufacturing Company to deliver advanced Electronic Design Automation and Intellectual Property solutions. Additionally, Keysight Technologies (NYSE:KEYS) has announced its intention to acquire Synopsys' Optical Solutions Group, pending the successful completion of Synopsys' acquisition of Ansys.

InvestingPro Insights

To complement Needham's analysis of Synopsys (NASDAQ:SNPS), recent data from InvestingPro offers additional perspective on the company's financial health and market position. Synopsys boasts a market capitalization of $77.67 billion, underscoring its significant presence in the software industry. The company's revenue for the last twelve months as of Q3 2024 stood at $6.48 billion, with an impressive revenue growth of 26.26% over the same period.

Synopsys's financial strength is evident in its gross profit margin of 80.5%, which aligns with the InvestingPro Tip highlighting the company's "impressive gross profit margins." This robust profitability supports Needham's optimistic outlook on the company's long-term growth potential in the EDA sector.

While Synopsys trades at a relatively high P/E ratio of 52.37, another InvestingPro Tip notes that "9 analysts have revised their earnings upwards for the upcoming period," suggesting continued confidence in the company's future performance. This positive sentiment is further reflected in the stock's fair value estimate of $643.5 based on analyst targets, which closely aligns with Needham's price target of $640.

For investors seeking a more comprehensive analysis, InvestingPro offers 16 additional tips on Synopsys, providing a deeper dive into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.